In conclusion, GJD may reduce blood pressure and improve left ventricular and aortic remodeling in a SHR model of hypertension by inhibiting inflammatory factors through NF-κB. Our data indicated that GJD might be used as an antihypertensive agent and provides scientific basis for further pharmacological studies and clinical applications. Here, NFKB1 is linked to hypertensive disorder.